41.31
-1.20 (-2.82%)
-1.20 (-2.82%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.20 | -2.82% | 41.31 | 16:55:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 40.52 | 40.02 | 42.29 | 41.31 | 42.51 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 41.31 | 42.79 | 1.48 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,022 | 310,651 | $ 41.37 | $ 12,850,601 | 636,483 | 20.03 - 50.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:44:05 | formt | 2,525 | $ 41.31 | USD |
REGENXBIO Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.75B | 42.31M | 28.51M | $ 35.23M | $ -17.20M | -2.59 | -17.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
REGENXBIO News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.92 | 43.00 | 37.7939 | 40.85 | 394,025 | 1.39 | 3.48% |
| 1 Month | 42.925 | 49.50 | 37.7939 | 44.03 | 369,581 | -1.62 | -3.76% |
| 3 Months | 36.29 | 50.26 | 35.68 | 45.07 | 548,598 | 5.02 | 13.83% |
| 6 Months | 29.46 | 50.26 | 25.925 | 38.64 | 444,815 | 11.85 | 40.22% |
| 1 Year | 39.68 | 50.26 | 20.03 | 36.73 | 425,430 | 1.63 | 4.11% |
| 3 Years | 28.20 | 85.10 | 20.03 | 46.41 | 496,649 | 13.11 | 46.49% |
| 5 Years | 12.575 | 85.10 | 7.0701 | 40.51 | 393,460 | 28.74 | 228.51% |
REGENXBIO Description
| Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |
